Lineage Cell Therapeutics, Inc. Insider Trading Activity

Also formerly known as BIOTIME INC
Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
3
Insider Sells Sum
$16.28M

Insider Activity of Lineage Cell Therapeutics, Inc.

Biography of Lineage Cell Therapeutics, Inc.

No biography is available at this moment.

2020-01-02SaleInsight Molecular Diagnostics Inc.
IMDX
2.38M
2.4011%
$2.16$5.14M-6.05%
2019-09-11SaleInsight Molecular Diagnostics Inc.
IMDX
10 percent owner
4M
3.1031%
$1.66$6.64M+18.75%
2019-07-05SaleInsight Molecular Diagnostics Inc.
IMDX
10 percent owner
2.25M
2.103%
$2.00$4.5M0%
Total: 3
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.